PharmEasy valuation drops 92% from peak to $458 million according to investor Janus Henderson
In a surprising turn of events, Indian e-pharmacy major PharmEasy's valuation has dropped substantially according to new estimates provided by one of its key investors. London-based global asset management firm Janus Henderson, in a recent…
Read More...
Read More...